Private Placements

 

 

 

 

Hedge Funds

 

 

 

 

Seaside 88, LLC

 

 

 

Strategy: Seaside has a narrowly focused business of providing smaller companies with growth capital in the form of an upfront payment in return for a share of future monthly revenues until Seaside achieves a negotiated return on its investment. This built-in exit strategy allows Seaside to focus on privately held companies without a need to await liquidity from an IPO or buyout.

 

Seaside strives to select companies that will use the capital infusion to accelerate their revenue growth through product launches, sales force expansion, entry into new geographic markets, etc. Companies suffer no dilution of their equity, and the pre-money valuation of a company is not a sticking point in closing a transaction.

 

Managing Partners: William J. Ritger has 25+ years of professional equity research experience, and Denis M. ODonnell, MD, has 20+ years of life science corporate management, as well as medical and clinical experience. The two managing partners have invested in more than 200 private placements over the past 20 years.

 

 

o

William J. Ritger. Investor in more than 200 equity private placements over multi decades and 25+ years of professional equity research experience. Founder & CEO of The Research Works, Inc. (1992-08), an equity research boutique. Earlier a senior research analyst at Dillon Read & Co., Inc.; Needham and Company, LLC; Dean Witter Reynolds, Inc.; Kidder Peabody & Co., Inc.; Argus Research Corporation; and Standard & Poors Corporation. Former Institutional Investor Magazine All-America research analyst in the emerging growth sector. Columbia Graduate School of Business Administration, MBA. Duke University, BA (Economics).

 

 

o

Denis M. ODonnell, MD. He and affiliated entities have invested in more than 100 private placements over the past 20 years. He and Mr. Ritger were the GP managers of two previous hedge funds. 20+ years in life science corporate management: founding President & Executive Chairman of Novavax, Inc., former CEO of Molecular Diagnostics, Inc., and former director of five publicly traded companies. Medical and clinical experience includes being an investigator on more than 400 FDA human clinical studies and a fellow at The American College of Clinical Pharmacology. AUC School of Medicine, MD. Harvard University, AB (Biology).

 

Website

 

Additional Information: Contact one of the Managing Partners to obtain a copy of the PPM. Investors must be qualified clients as defined by Rule 205-3 of the Advisers Act (here). [The offering is not available to residents of NY.] Many of the risks of this Company are detailed in the Seaside 88 offering documents, which are hereby incorporated by reference.

 

Contacts: William J. Ritger (Juno Beach, FL) at 561.891.1903 or wjr@seaside88.com; and Dr. Denis ODonnell (Gloucester, MA) at 781.789.3173 or dod@seaside88.com.

 

 

 

Index of Private Placements & Hedge Funds

 

PBHFA Home

 

Here is a link to information on our comprehensive investor awareness program.

For more detailed information, please contact one of the following individuals:

 

William J. Ritger at 561.891.1903 or writger@gmail.com

David Goodboy at 561.349.7300 or dave@pbhfa.org

 

 

The Deal Flow section of this website is operated jointly by Palm Beach Hedge Fund Association, Inc., a Florida corporation, and TickerBuzz, LLC, a Florida limited liability company. Neither PBHFA nor TickerBuzz are registered broker-dealers, and they do not give investment advice, endorsement, analysis, or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this site is the responsibility of the applicable issuer of such securities. Neither PBHFA nor TickerBuzz have taken any steps to verify the adequacy, accuracy, or completeness of any information, and neither PBHFA nor TickerBuzz nor any of their officers, directors, agents, and employees make any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. By accessing this site and any pages thereof, you agree to be bound by the PBHFA Terms of Use and Privacy Policy. Neither PBHFA nor TickerBuzz make investment recommendations, and no communication, through this website or in any other medium, should be construed as a recommendation for any security offered on or off this investment platform. Equity crowdfunding investments in private placements, and start-up investments in particular, are speculative and involve a high degree of risk, and those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investments through equity crowdfunding tend to be in earlier stages of development, and their business model, products, and services may not yet be fully developed, operational, or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Additionally, investors may receive illiquid and/or restricted stock that may be subject to holding period requirements and/or liquidity concerns. In the most sensible investment strategy for start-up investing, start-ups should only be part of your overall investment portfolio. Further, the start-up portion of your portfolio may include a balanced portfolio of different start-ups. Investments in start-ups are highly illiquid, and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.

 

This Profile is intended for discussion purposes only; the only definitive source of information regarding this offering is the Company offering documents. This Profile is not a solicitation to buy or sell any security, and must not be relied upon for financial, legal, tax, or any other professional advice. Investor prospects should also carefully research and consider the risks inherent in this investment. The information in this Profile is applicable only as of the date of this Profile and is subject to change without prior notice. Past performance is not indicative of future results. The editor of this Profile is a Managing Member of TickerBuzz. The editor of this Profile is one of the managing partners of this Company. Neither PBHFA nor TickerBuzz take any compensation relating to the success of any securities offering. October 29, 2020.

 

 

 

Web Hits